DOPAMINERGIC GRAFTS IN THE STRIATUM REDUCE D1 BUT NOT D2 RECEPTOR-MEDIATED ROTATION IN 6-OHDA-LESIONED RATS

被引:29
|
作者
ROBERTSON, GS
FINE, A
ROBERTSON, HA
机构
[1] DALHOUSIE UNIV,FAC MED,DEPT PHARMACOL,HALIFAX B3H 4H7,NS,CANADA
[2] DALHOUSIE UNIV,FAC MED,DEPT PHYSIOL & BIOPHYS,HALIFAX B3H 4H7,NS,CANADA
关键词
NEURAL TRANSPLANTATION; D1; RECEPTOR; D2; ROTATION; STRIATUM; SUBSTANTIA NIGRA;
D O I
10.1016/0006-8993(91)91634-D
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rats received fetal dopaminergic neuronal grafts in the striatum and/or substantia nigra ipsilateral to a 6-hydroxydopamine (6-OHDA) lesion of the medial forebrain bundle (MFB). Dopaminergic grafts in the striatum substantially and significantly reduced turning elicited by the selective D1 agonist SKF 38393, but did not reduce turning elicited by the selective D2 agonist LY 171555. Thus, reduced turning in such grafted animals in response to non-selective dopaminergic agonists may be the result of diminished D1 supersensitivity. Fetal dopaminergic grafts in the ipsilateral substantia nigra (SN) did not augment the decreases in turning produced by concomitant ipsilateral dopaminergic grafts in the striatum in response to SKF 38393, LY 171555, D-amphetamine or L-DOPA. Dopaminergic grafts in the SN increased, while dopaminergic grafts in the striatum or in striatum and SN decreased, the facilitatory effect of D-amphetamine on rotation elicited by subsequent injection of dopamine agonists.
引用
收藏
页码:304 / 311
页数:8
相关论文
共 50 条
  • [41] Continuous dopaminergic stimulation counteracts l-DOPA-induced overactivity of Ca2+ in 6-OHDA-lesioned rats
    Fu, Jie
    Zhao, Xinyu
    Tian, Fugang
    Yu, Xin
    EXPERIMENTAL BRAIN RESEARCH, 2022, 240 (7-8) : 1933 - 1941
  • [42] DOPAMINE D1/D2 RECEPTOR INTERACTION
    SASA, M
    AKAIKE, A
    OHNO, Y
    HARA, M
    TAKAORI, S
    JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1991, 45 (02): : 507 - 510
  • [43] The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum
    Centonze, Diego
    Rossi, Silvia
    Napoli, Ilaria
    Mercaldo, Valentina
    Lacoux, Caroline
    Ferrari, Francesca
    Ciotti, Maria Teresa
    De Chiara, Valentina
    Prosperetti, Chiara
    Maccarrone, Mauro
    Fezza, Filomena
    Calabresi, Paolo
    Bernardi, Giorgio
    Bagni, Claudia
    JOURNAL OF NEUROSCIENCE, 2007, 27 (33): : 8885 - 8892
  • [44] Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors
    Centonze, D
    Usiello, A
    Gubellini, P
    Pisani, A
    Borrelli, E
    Bernardi, G
    Calabresi, P
    NEUROPSYCHOPHARMACOLOGY, 2002, 27 (05) : 723 - 726
  • [45] Dopamine D2 Receptor-Mediated Inhibition of Dopaminergic Neurons in Mice Lacking D2L Receptors
    Diego Centonze
    Alessandro Usiello
    Paolo Gubellini
    Antonio Pisani
    Emiliana Borrelli
    Giorgio Bernardi
    Paolo Calabresi
    Neuropsychopharmacology, 2002, 27 : 723 - 726
  • [46] AUTORADIOGRAPHIC STUDY OF STRIATAL D1-DOPAMINE AND D2-DOPAMINE RECEPTORS IN 6-OHDA-LESIONED RATS RECEIVING FETAL VENTRAL MESENCEPHALIC GRAFTS AND CHRONIC TREATMENT WITH L-DOPA AND CARBIDOPA
    BLUNT, SB
    JENNER, P
    MARSDEN, CD
    BRAIN RESEARCH, 1992, 582 (02) : 299 - 311
  • [47] THE ROLE OF D1 AND D2 DOPAMINE-RECEPTORS IN ORAL STEREOTYPY INDUCED BY DOPAMINERGIC STIMULATION OF THE VENTROLATERAL STRIATUM
    DELFS, JM
    KELLEY, AE
    NEUROSCIENCE, 1990, 39 (01) : 59 - 67
  • [48] Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats
    Pollack, AE
    Yates, TM
    NEUROSCIENCE, 1999, 94 (02) : 505 - 514
  • [49] Hypothyroidism affects D2 receptor-mediated breathing without altering D2 receptor expression
    Schlenker, Evelyn H.
    Del Rio, Rodrigo
    Schultz, Harold D.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2014, 193 : 29 - 37
  • [50] Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D1 but not D2 receptor agonists
    Cauli, O
    Pinna, A
    Morelli, M
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 (08): : 621 - 626